Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain

被引:121
作者
Sanberg, PR
Borlongan, CV
Saporta, S
Cameron, DF
机构
[1] UNIV S FLORIDA,COLL MED,DEPT NEUROL,TAMPA,FL 33612
[2] UNIV S FLORIDA,COLL MED,DEPT PSYCHIAT,TAMPA,FL 33612
[3] UNIV S FLORIDA,COLL MED,DEPT PHARMACOL,TAMPA,FL 33612
[4] UNIV S FLORIDA,COLL MED,DEPT ANAT,TAMPA,FL 33612
关键词
Sertoli cells; neural transplantation; Parkinson's disease; xenotransplantation; striatum;
D O I
10.1038/nbt1296-1692
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Transplantation of neural tissue into the mammalian central nervous system has become an alternative treatment for neurodegenerative disorders such as Parkinson's disease. Logistical and ethical problems in the clinical use of human fetal neural grafts as a source of dopamine for Parkinson's disease patients has hastened a search for successful ways to use animal dopaminergic cells for human transplantation. The present study demonstrates that transplanted testis-derived Sertoli cells into adult rat brains survive. Furthermore, when cotransplanted with bovine adrenal chromaffin cells (xenograft), Sertoli cells produce localized immunoprotection, suppress microglial response and allow the bovine cells to survive in the rat brain without continuous systemic immunosuppressive drugs. These novel features support Sertoli cells as a viable graft source for facilitating the use of xenotransplantation for Parkinson's disease and suggest their use as facilitators (i.e., localized immunosuppression) for cell transplantation in general.
引用
收藏
页码:1692 / 1695
页数:4
相关论文
共 22 条
[1]  
BARKER CF, 1977, ADV IMMUNOL, V25, P1
[2]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632
[3]  
BERDEN JHM, 1985, LANCET, V1, P219
[4]   CROSS-SPECIES NEURAL GRAFTING IN A RAT MODEL OF PARKINSONS-DISEASE [J].
BJORKLUND, A ;
STENEVI, U ;
DUNNETT, SB ;
GAGE, FH .
NATURE, 1982, 298 (5875) :652-654
[5]  
Bjorklund A., 1985, NEURAL GRAFTING MAMM, P3
[6]  
BRUNDIN P, 1989, EXP BRAIN RES, V75, P195
[7]  
DEGROEN C, 1984, NEW ENGL J MED, V317, P861
[8]   A NOVEL-APPROACH TO NEURAL TRANSPLANTATION IN PARKINSONS-DISEASE - USE OF POLYMER-ENCAPSULATED CELL THERAPY [J].
EMERICH, DF ;
WINN, SR ;
CHRISTENSON, L ;
PALMATIER, MA ;
GENTILE, FT ;
SANBERG, PR .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1992, 16 (04) :437-447
[9]  
FINSEN B, 1988, EXP BRAIN RES, V70, P117
[10]  
FINSEN BR, 1991, RESTOR NEUROL NEUROS, V2, P271, DOI 10.3233/RNN-1991-245616